P8B-17583-12471
3 vaccinations
7 coded responses
15 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 430 / OH
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-02-09
Dose 2 — Pfizer-BioNTech
-
2021-02-11
Registered in v-safe
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-03-16
Survey response — day 35, dose 2MedDRA: Diarrhoea — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: DiarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — day 42, dose 2MedDRA: Diarrhoea — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: DiarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Survey response — 3 months, dose 2MedDRA: Drug hypersensitivity — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Allergic reaction to antibioticMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Bursitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: BursitisMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-17
- 2021-08-17
-
2021-12-14
Dose 3 — Pfizer-BioNTech
-
2022-02-09
Survey response — 12 months, dose 2MedDRA: Diarrhoea, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Diarrhea, nausea.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-11
-
2022-06-14
Survey response — 6 months, dose 3MedDRA: Chills, Diarrhoea, Headache, Myalgia, Nausea, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend schoolFree text: Congestion, nausea, fever, chills, muscle aches, headache, diarrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Survey response — 12 months, dose 3MedDRA: Chest discomfort, Chest pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Chest pain, chest pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-12-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-15
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-12-14 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
1 wait over 3 months for a first call
Free text
Release 5 — day 35, dose 2
Symptoms: Diarrhea
Release 6 — day 42, dose 2
Symptoms: Diarrhea
Release 8 — 3 months, dose 2
Symptoms: Allergic reaction to antibiotic
Release 9 — 6 months, dose 2
Symptoms: Bursitis
Release 11 — 12 months, dose 2
Symptoms: Diarrhea, nausea.
Release 12 — 6 months, dose 3
Symptoms: Congestion, nausea, fever, chills, muscle aches, headache, diarrhea
Release 12 — 12 months, dose 3
Symptoms: Chest pain, chest pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bursitis | ✓ | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Drug hypersensitivity | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release